gingko biloba
PRODUCT EXAMPLES
In the two clinical trials, both had used two different Gingko biloba products in the treatment of PMS. The two products used were Gingko Biloba L 40mg-coated tablets with flavonoid glycoside 24% and terpene lactone 6% and an Egb1 extract of Gingko Biloba.1,2
Brand: Dr. Andrew Weil, M.D. Ginkgo Biloba
Maker: Jamieson Laboratories Ltd.
NPN: 80003088
Content: Gingko biloba 60 mg - 24.0 % ginkgoflavonglycosides, 6.0 % terpene lactones
Brand: Gingko Biloba Leaves Extract
Maker: Immune System Managements Inc.
NPN: 80003085
Content: Gingko biloba 20 mg/ml oral liquid - 24.0 % flavone glycosides, 6.0% terpene lactones
Brand: Ginkgo Biloba
Maker: Orbus Pharma Inc.
NPN: 80000241
Content: Gingko biloba 40mg capsule - 24.0 % ginkgoflavonoids
Brand: Pleo Ginkgo
Maker: Biomed International Products Corp.
NPN: 80002537
Content: Gingko biloba 1.0 D oral liquid. Homeopathic.
References:
1. Ozgoli G, Selselei EA, Mojab F, and Majd HA. A Randomized, Placebo-Controlled Trial of Gingko biloba L. in Treatment of Premenstrual Syndrome. J Alternative and Complementary Med. 15 (8): 2009 pp 845-851. DOI: 10.1089=acm.2008.0493.
2. Tamborini A, and Taurelle R. Value of standardized Gingko biloba extract (EGb 761) in the management of premenstrual syndrome. Revue francaise de gynecologie et d’obstretqieu. 88 (7-9): 1993 pp 447-457.
3. Health Canada. Licensed Natural Health Product Database. Accessed July 18, 2013. From: < http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php>
Brand: Dr. Andrew Weil, M.D. Ginkgo Biloba
Maker: Jamieson Laboratories Ltd.
NPN: 80003088
Content: Gingko biloba 60 mg - 24.0 % ginkgoflavonglycosides, 6.0 % terpene lactones
Brand: Gingko Biloba Leaves Extract
Maker: Immune System Managements Inc.
NPN: 80003085
Content: Gingko biloba 20 mg/ml oral liquid - 24.0 % flavone glycosides, 6.0% terpene lactones
Brand: Ginkgo Biloba
Maker: Orbus Pharma Inc.
NPN: 80000241
Content: Gingko biloba 40mg capsule - 24.0 % ginkgoflavonoids
Brand: Pleo Ginkgo
Maker: Biomed International Products Corp.
NPN: 80002537
Content: Gingko biloba 1.0 D oral liquid. Homeopathic.
References:
1. Ozgoli G, Selselei EA, Mojab F, and Majd HA. A Randomized, Placebo-Controlled Trial of Gingko biloba L. in Treatment of Premenstrual Syndrome. J Alternative and Complementary Med. 15 (8): 2009 pp 845-851. DOI: 10.1089=acm.2008.0493.
2. Tamborini A, and Taurelle R. Value of standardized Gingko biloba extract (EGb 761) in the management of premenstrual syndrome. Revue francaise de gynecologie et d’obstretqieu. 88 (7-9): 1993 pp 447-457.
3. Health Canada. Licensed Natural Health Product Database. Accessed July 18, 2013. From: < http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php>